BELUJON Pauline

pauline-belujon-188x250

EQUIPE de rattachement : Equipe Neurobiologie et Neuropharmacologie de l’Addiction

NOM Prénom : Belujon Pauline

Statut (date de début-fin prévue si CDD): MCU

Adresse :

Laboratoire de Neurosciences Expérimentales et Cliniques

Bât B36, Pôle Biologie Santé

1, rue Georges Bonnet

86073 Poitiers Cedex 9 France

Tél : +33 5 49 45 38 53

e-mail :pauline.belujon@univ-poitiers.fr

Publications (toutes les marquantes, y compris avant 2012):

  • Belujon P., Jakobowski N.L., Dollish H.K. and Grace A.A. “Withdrawal from Acute amphetamine induces an amygdala-driven attenuation of dopamine neuron activity: reversal by ketamine” Neuropsychopharmacology. 2016 Jan;41(2):619-27
  • Belujon P. and Grace A.A. “Regulation of dopamine system responsivity and its adaptive and pathological response to stress” Proceedings of the Royal Society of London B. 2015 Apr 22;282(1805) (review)
  • Belujon P. and Grace A.A. “Restoring balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity” Biological Psychiatry, 2014 Dec 15;76(12):927-36
  • Belujon P., Patton M.H., Grace A.A. “Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia.” Cerebral Cortex, 2014 Apr;24(4):968-77
  • Belujon P. and Grace A.A. “Hippocampus, amygdala and stress: Interacting systems that affect susceptibility to addiction” Annals of the New-York Academy of Science 2011 Jan;1216:114-21 (review)
  • Belujon P. and Grace A.A. “Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flowThe Journal of Neuroscience, September 24, 2008 • 28(39):9797–606
  •  Belujon P., Bezard E., Bioulac B., Taupignon A.I., Benazzouz A.“Noradrenergic modulation of subthalamic nucleus: behavioral and electrophysiological evidence” The Journal of Neuroscience, September 5, 2007 • 27(36):9595–805

Recherche

Menu principal

Haut de page